Key Facts Surrounding This News Item
- ZEAL had returned 0.00% year-to-date leading up to today’s news, versus a +11.64% return from the benchmark S&P 500 during the same period.
More Info About Zealand Pharma A/S (ZEAL)
Zealand Pharma A/S, a biotech company, engages in the discovery, design, and development of novel peptide-based medicines in Denmark. The company was founded in 1997 and is based in Copenhagen, Denmark. View our full ZEAL ticker page with ratings, news, and more.